TOPICAL QUESTIONS OF MEDICAL AND BIOLOGICAL SUPPORT OF CHILDREN’S AND YOUTH SPORTS
https://doi.org/10.21508/1027-4065-2018-63-5-231-236
Abstract
An effective system of children’s and youth sports, selection and preparation of a the reserve for national teams predetermines the success of athletes in international competitions. Therefore, the development of medical and biological support of children’s sports is an important part of sports medicine. It is proved that when building a training process for different ages, it is necessary to take into account the adaptation processes, as well as the energy supply of the child’s organism. Based on numerous studies, we can conclude that mitochondria play the most important role in the process of energy supply, as well as carnitine, a substance that is a carrier of long chain fatty acids into the cytosol, an activator of beta oxidation and the Krebs cycle. Timely detection of factors adversely affecting and limiting physical activity at the macro level (overtraining, incompatibility of physical activity with the body capabilities) and at the micro level (carnitine deficiency), the ability to eliminate these factors and the adequate use of correction tools help to achieve high results in sports and preserve the health of the athlete.
About the Authors
N. V. Rylova
Kazan State Medical University.
Russian Federation
Russian Federation
A. A. Biktimirova
Kazan State Medical University.
Russian Federation
Russian Federation
A. A. Imamov
Kazan State Medical University.
Russian Federation
Russian Federation
A. V. Zholinsky
Federal Scientific and Clinical Center for Sports Medicine and Rehabilitation.
Russian Federation
Russian Federation
References
1. Order of the government of the Russian Federation about the approval of Strategy of development of physical culture and sport in the Russian Federation for the period till 2020 of 7.08.2009 No. 1101-p. https://www.minsport.gov.ru/activities/federal-programs/2/26363/ (in Russ)
2. Biktimirova A.A., Rylova N.V., Zolkina I.V., Kulagina T.E., Sukhorukov V.S. Carnitine metabolic features in young athletes. Ros Vestn Perinatol i Pediat ( Russian Bulletin of Perinatology and Pediatrics) 2015; 60(2): 105–107. (in Russ)
3. Sports Medicine. National leadership. S.P. Mironov, B.A. Polyaeva, G.A. Makarova (eds). Moscow: GEOTAR-Medi, 2013; 1184. (in Russ)
4. Golov V.A. Youth sport in the system of development of physical culture of students. Uspekhi sovremennogo estestvoznaniya 2008; 1: 65–68. (in Russ)
5. Rychkova T.I., Ostroukhova I.P., Yatskov S.A., Akulova L.K., Vasilyeva T.M. Correction of functional changes in the cardiovascular system with L-carnitine in children and adolescents with combined pathology. Lechashhij vrach 2010; 8: 104–108. (in Russ)
6. Tvorogova T.M., Zakharova I.N., Korovin N.Ah. Tarasova A.A., Khrunova K.M. Correction of cardiac changes in vegetative dystonia in children and adolescents: emphasis on the effectiveness of energy-stimulating therapy. Consilium Medicum. Pediatriya 2009; 3: 109–114. (in Russ)
7. Biktimirova A.A., Rylova N.V., Samoilov A.S. Application of cardiorespiratory exercise testing in sports medicine. Prakticheskaya meditsina 2014; 3(79): 50–53. (in Russ)
8. Zhitnikova L.M. Trimetazidine in metabolic therapy of cardiovascular diseases. Russkij meditsinskij zhurnal 2012; 12: 718–723. (in Russ)
9. Ostman B., Sjödin A., Michaëlsson K., Byberg L. Coenzyme Q10 supplementation and exercise-induced oxidative stress in humans. Nutrition 2012; 28 (4): 403–417. DOI: 10.1016/j.nut.2011.07.010.
10. Demidov V.A., Hasnutdinov N.S., Mavliev F.A., Malcev D.N. Gender features of short-term adaptation of the cardiovascular system to dosed physical activity. Vestnik Yuzhno-Ural’skogo Gosudarstvennogo Universiteta 2008; 19: 135–137. (in Russ)
11. Sukhorukov V.S. The mitochondrial pathology and problems of pathophysiology of mental disorders. S.S. Korsakov Journal of Neurology and Psychiatry (Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova) 2008; 6: 83–90. (in Russ)
12. Tsaregorodtsev A.D., Sukhorukov V.S. Mitochondrial medicine: Problems and tasks. Ros Vestn Perinatol i Pediat (Russian Bulletin of Perinatology and Pediatrics) 2012; 57(4: 2): 5–14. (in Russ)
13. Balykova L.A., Ivjanskij S.A., Makarov L.M., Markelova I.A., Kiseleva M.I., Balashov V.P. Prospects of metabolic therapy in children’s sports cardiology. Pediatria. Journal named after G.N.Speransky 2009; 88(5): 7–13. (in Russ)
14. Eynon N., Moran M., Birk R., Lucia A. The champions’ mitochondria: is it genetically determined? A review on mitochondrial DNA and elite athletic performance. Physiological Genomics 2011; 43: 789–798. DOI: 10.1152/physiolgenomics.00029.2011
15. Fatouros I.G., Douroudos I., Panagoutsos S., Pasadakis P., Nikolaidis M.G., Chatzinikolaou A., Sovatzidis A. et al. Effects of L-carnitine on oxidative stress responses in patients with renal disease. Med Sci Sports Exerc 2010; 42(10): 1809–1811. DOI: 10.1249/MSS.0b013e3181dbacab
16. Orer G., Guzel N. The effects of acute L-carnitine supplementation on endurance performance of athletes. J Strength Cond Res 2014; 28(2): 514–519. DOI: 10.1519/JSC.0b013e3182a76790
17. Асташкин Е.И., Глезер М.Г. Роль L-карнитина в энергетическом обмене кардиомиоцитов и лечении заболеваний сердечно-сосудистой системы. Кардиология и сердечно-сосудистая хирургия 2012; 6(2): 58–65. [Astashkin E.I., Glezer M.G. Тhe role of l-carnitine in the energetic metabolism of cardiomyocytes and treatment of cardio-vascular diseases. Kardiologiya i serdechno-sosudistaya khirurgiya 2012; 6(2): 58–65. (in Russ)]
18. Yakovleva L.V., Bezchasnuk E.M., Ulesov A.V., Khomyakova L.G., Shapoval O.N., Zborovskaya T.V. L-carnitine: characteristic, preparations, medicinal using. Ukr zhurn klіn ta lab med 2011; 6(2): 17–24. (in Russ)
19. Alyamovskaya G.A., Zolkina I.V., Keshishian E.S. Secondary carnitine deficiency in low birth weight (less than 1500 g) premature infants in the pathogenesis of energy deficiency during their first-second years of life and possibilities of its correction. Ros Vestn Perinatol i Pediat ( Russian Bulletin of Perinatology and Pediatrics) 2012; 4(2): 126–131. (in Russ)
20. Leont’eva I.V., Alimina E.G., Zolkina I.A. Evaluation of carnitine metabolism clinical aspects in children with cardiomyopathy. Praktika pediatra 2012; 10: 47–52. (in Russ)
21. Kljuchnikov S.O., Il’jashenko D.A., Kljuchnikov M.S. Efficiency of Karniton and Qudesan to adolescents. Clinical- functional and psychological research. Praktika pediatra 2009; 2: 23–27. (in Russ)
22. Bokova T.A. L-carnitine in a complex therapy of metabolic syndrome in children Voprosy prakticheskoy pediatrii 2010; 5(4): 96–98. (in Russ)
23. Kamchatnov P.R. Application of carnitine (Elkar) and its derivative acetyl-l-carnitine (Carnicetin) in clinical practice. Manual. Moscow 2010; 20 (in Russ)
24. Nikolaeva E.A., Zolkina I.V., Kharabadze N.M. Correction of carnitine deficiency in children with mitochondrial diseases. Praktika pediatra 2011; 5: 44–48. (in Russ)
25. Mizuno K., Tanaka M., Nozaki S., Mizuma H., Ataka S., Tahara T., Sugino T. et al. Antifatigue effects о f coenzyme Q10 during physical fatigue. Nutrition 2008; 24(4): 293–299. DOI: 10.1016/j.nut.2007.12.007
26. Kreider R., Wilborn C., Taylor L., Campbell B., Almada A., Collins R., Cooke M. et al. ISSN exercise & sport nutrition review: research & recommendations. J Intern Soc Sports Nutrit 2010; 7: 7–11. DOI: 10.1186/1550-2783-7-7
27. Sharma S., Black S. Сarnitine homeostasis, mitochondrial function, and cardiovascular disease. Drug Discov Today Dis Mech 2009; 6: 1–4: e31–e39. DOI: 10.1016/j.ddmec.2009.02.001
Review
For citations:
Rylova N.V., Biktimirova A.A., Imamov A.A., Zholinsky A.V. TOPICAL QUESTIONS OF MEDICAL AND BIOLOGICAL SUPPORT OF CHILDREN’S AND YOUTH SPORTS. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2018;63(5):231-236. (In Russ.) https://doi.org/10.21508/1027-4065-2018-63-5-231-236
Views:
1120
Email this article 